Title |
Experiencing challenges when implementing Active Management of Third Stage of Labor (AMTSL): a qualitative study with midwives in Accra, Ghana
|
---|---|
Published in |
BMC Pregnancy and Childbirth, June 2014
|
DOI | 10.1186/1471-2393-14-193 |
Pubmed ID | |
Authors |
Stina Mannheimer Schack, Amna Elyas, Gladys Brew, Karen Odberg Pettersson |
Abstract |
Post-partum hemorrhage (PPH) is the major cause of maternal mortality in Ghana and worldwide. Active management of the third stage of labor (AMTSL) is a globally recommended three-step method that in clinical trials has been proven effective in prevention of PPH. The AMTSL guidelines were introduced in 2003, modified in 2006, and has been part of the national guidelines in Ghana since 2008. In 2012, the guidelines were modified a second time. Despite its positive effects on the incidence of PPH, the level of adherence to the guidelines seems to be low in the studied area. This appears to be a problem shared by several countries in the region. An in-depth understanding of midwives' experiences about AMTSL is important as it can provide a basis for further interventions in order to reach a higher grade of implementation. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 50% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Kenya | 1 | <1% |
Unknown | 141 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 35 | 24% |
Student > Bachelor | 16 | 11% |
Student > Ph. D. Student | 14 | 10% |
Student > Postgraduate | 10 | 7% |
Researcher | 6 | 4% |
Other | 21 | 15% |
Unknown | 41 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 40 | 28% |
Nursing and Health Professions | 35 | 24% |
Social Sciences | 9 | 6% |
Unspecified | 3 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
Other | 11 | 8% |
Unknown | 42 | 29% |